Baiben Healthcare (02293.HK) received an increase of 64,000 common shares by Xi Xiaozhu, worth approximately HK$41,600
On April 9, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on April 9, Xi Xiaozhu increased his common stock holdings of $100 Healthcare (02293.HK) by $64,000 at an average price of HK$0.65 per share on April 5, worth about HK$41,600. After the increase in holdings, Xi Xiaozhu's latest shareholding was 271 million shares, and the good position ratio rose from 67.28% to 67.30%. Photo Source: Stock Exchange Equity Disclosure What is equity disclosure? As required by the Hong Kong Stock Exchange, major shareholders (individuals and companies holding 5% or more of the shares) are required to disclose their share interests in listed companies. Directors and directors of listed companies
Baiben Healthcare (02293.HK) received 600,000 additional shares of common stock by Xi Xiaozhu, worth approximately HK$389,400
On April 9, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on April 9, Xi Xiaozhu increased his common stock holdings of $100ben Healthcare (02293.HK) by $600,000 at an average price of HK$0.649 per share on April 3, worth about HK$389,400. After the increase in holdings, Xi Xiaozhu's latest shareholding was 271 million shares, and the good position ratio rose from 67.13% to 67.28%. Photo Source: Stock Exchange Equity Disclosure What is equity disclosure? As required by the Hong Kong Stock Exchange, major shareholders (individuals and companies holding 5% or more of the shares) are required to disclose their share interests in listed companies. directors of listed companies and
BAMBOOSHEALTH: Interim Report 2023/2024
BAMBOOSHEALTH To Go Ex-Dividend On March 11th, 2024 With 0.05 HKD Dividend Per Share
February 28th - $BAMBOOSHEALTH(02293.HK)$ is trading ex-dividend on March 11th, 2024. Shareholders of record on March 12th, 2024 will receive 0.05 HKD dividend per share on March 22nd, 2024. The e
100 Healthcare (02293) will pay an interim dividend of HK$0.05 per share on March 22
Baiben Healthcare (02293) announced that the company will pay an interim dividend of 0 per share on March 22, 2024...
Medium-term net profit of Baiben Healthcare (02293.HK) decreased by 44.1% to HK$17.1 million
On February 27, GLONGHUI | Baiben Healthcare (02293.HK) announced that for the six months ended December 31, 2023, revenue was approximately HK$49.7 million, a year-on-year decrease of about 26.6%; profit attributable to the company's equity holders was approximately HK$17.1 million, a decrease of about 44.1% year-on-year. Basic and diluted earnings per share were HK4.28 cents.
百本醫護:截至二零二三年十二月三十一日止六個月之 中期業績公告
Hyakbon Healthcare (02293.HK): Issuance of 2.46 million shares under the share incentive plan
On December 14, Gelonghui announced that on December 14, Baiben Healthcare (02293.HK) announced that on December 14, 2023, 2.46 million new shares will be issued and distributed to 21 beneficiaries' trustees under the share reward plan.
BAMBOOSHEALTH: ANNUAL REPORT 2023
BAMBOOSHEALTH To Go Ex-Dividend On December 1st, 2023 With 0.0375 HKD Dividend Per Share
September 27th - $BAMBOOSHEALTH(02293.HK)$ is trading ex-dividend on December 1st, 2023. Shareholders of record on December 4th, 2023 will receive 0.0375 HKD dividend per share on December 13th, 2
The annual net profit of Bauben Healthcare (02293.HK) decreased by approximately 20.0% to approximately HK$46.9 million, with a final interest rate of 3.75 HK cents
GLONGHUI, September 26丨Baiben Healthcare (02293.HK) announced that for the year ended June 30, 2023, the company's revenue was approximately HK$127 million, a year-on-year decrease of about 9.8%. Profit attributable to equity holders of the company was approximately HK$46.9 million, a year-on-year decrease of approximately 20.0%. The recommended final dividend is HK3.75 cents per common share (2022: HK5.00 cents per common share).
Bauben Healthcare (02293) announced annual results. Profit attributable to shareholders was approximately HK$46.9 million, a year-on-year decrease of about 20%
Hyakuben Healthcare (02293) announced its results for the year ended June 30, 2023, with revenue of approximately HK$126.6 million...
BAMBOOSHEALTH: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 30 JUNE 2023
BAMBOOSHEALTH: DATE OF BOARD MEETING
Bamboos Health Care Holdings' Fiscal H1 Profit Stays Nearly Flat; Shares Down 3%
04:06 AM EDT, 03/27/2023 (MT Newswires) -- Bamboos Health Care Holdings' (HKG:2293) fiscal first-half profit remained nearly flat in 2022 at HK$30 million from HK$30.3 million in the year-ago period,
Hyakubon Healthcare: 2022/2023 Interim Report
Baiben Healthcare (02293) announced interim results. The profit attributable to shareholders of HK$30.6 million decreased 8.7% year-on-year
According to the Zhitong Finance App, Baiben Healthcare (02293) announced its interim results announcement for the six months ending December 31, 2022. The company achieved revenue of HK$67.7 million, a decrease of about 7.2% over the previous year; profit attributable to shareholders of HK$30.6 million, a decrease of about 8.7% over the previous year; profit of 7.65 Hong Kong cents per share and an interim dividend of HK$3.75 per common share. According to the announcement, revenue from providing services related to outreach case assessment fell by about HK$16.6 million to about HK$4.2 million during the period, mainly due to medical and health assessment services (particularly community vaccination centres in Hong Kong, China)
Baibon Healthcare (02293) will pay an interim interest of HK$0.0375 per share on March 23
According to the Zhitong Finance App, Baiben Healthcare (02293) announced that on March 23, 2023, the company will pay an interim dividend of HK$0.0375 per share for the six months ending December 31, 2022.
Hyakuben Healthcare: Interim Results Announcement for the Six Months Ended December 31, 2022
Hyakubon Healthcare: Supplemental Announcement - Date of Board Meeting
No Data